PA-BENTLEY-SYSTEMS
10.11.2022 22:44:35 CET | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced advancements to its construction management solution with enhancements to SYNCHRO 4D and the addition of SYNCHRO Cost and SYNCHRO Perform applications. The new advancements and portfolio expansion enable construction firms to transform how they plan, manage, and execute their projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221110006078/en/
Virtual construction, planning, and model-based workflows from the field to office. Image courtesy of Bentley Systems.
“SYNCHRO helps The Lane Construction Corporation have access to all our project-level data. Our field and corporate managers, along with the executives who lead them, now have timely access to critical business information through SYNCHRO,” said Andy Kaiyala, former vice president of bid development, The Lane Construction Corporation. “It is access to this information that helps improve forward-looking decision-making. Our industry has been far too reliant on backward-looking reports and analysis. It is time to start looking ahead and planning for success. SYNCHRO helps us make a plan that we can rely on.”
SYNCHRO 4D now offers advanced 4D/5D model authoring with leading-edge model-splitting tools to create constructible components, assignment of construction attributes to the model, mixed reality modeling, construction geometry placement, and web and mobile access to improve team collaboration, status updates, and progress reporting from the field. The addition of SYNCHRO Cost helps project teams control budgets and track financial progress throughout the contract with support for multicontract capture, payment application tracking, and change order management, minimizing financial risk and maximizing project profits. SYNCHRO Perform enables construction performance management including the ability to capture daily progress quantities, diaries, unplanned events, timesheets, tickets, and estimated field costs to provide the shortest cycle time for project feedback and productivity insights.
Construction firms are striving to deliver more complex projects, address resource gaps and supply chain disruptions, and manage data transparency issues while trying to win more work, manage risk, and deliver profitability. SYNCHRO’s advancements in leveraging 4D/5D models with web access for team collaboration, performance management for progress tracking and reporting, and cost management to minimize risk and maximize profits will transform the way projects are planned and delivered – with digitized workflows to address these challenges.
Leading-edge construction firms are using 4D models to build and optimize schedules and communicate sequencing and staging in a virtual environment. Digital rehearsals are a core part of their planning process to ensure resources are optimized, reducing rework and increasing safety. With the enhancements to SYNCHRO 4D, the accessibility and value of the 4D model is extended to more project stakeholders. The new capabilities improve communication and coordination of optimized plans, enabling real-time collaboration and model-based field-collected data to ensure projects stay on track.
“Construction teams need to ensure that they are in control of both the schedule and costs of their projects,” said Rich Humphrey, vice president of construction at Bentley Systems. “The addition of SYNCHRO Cost and SYNCHRO Perform extends SYNCHRO’s industry leading 4D scheduling and project management solutions to include more capabilities to help contractors manage their costs and effectively connect the planning and tracking of costs and schedule. Time is money and we want project teams to save more of both with SYNCHRO.”
SYNCHRO Cost works with SYNCHRO 4D’s model-based quantity take-off, which includes model splitting to generate constructible components complete with work breakdown structure and cost codes so that estimators can quickly and accurately generate estimates. Moreover, SYNCHRO Cost can control contract changes and simplify payment applications, tracking line items and percentage complete against a schedule of values.
SYNCHRO Cost leverages the performance data in SYNCHRO Perform so project teams can manage and leverage field performance data to gain an accurate picture of actual costs from the field to compare to planned costs and schedule, delivering a complete view of the project’s performance. These digital workflows better connect the office and job site with real-time information. Supplementing contracts and change orders with evidentiary documents and images can prove invaluable in avoiding contract disputes.
With daily, clear line-of-sight into the management of all site resources from staff, sub-contractors, and equipment, SYNCHRO Perform fills the gaps between end-of-month financial reporting cycles. And, with project leadership potentially at a disadvantage when it comes to decision-making due to delays in progress capture and errors in data entry, SYNCHRO Perform provides a timely source of truth for all performance management data and metrics, so that project leadership knows the health of every project. Construction-specific features capture daily progress quantities, diaries, unplanned events, timesheets, tickets, and estimated costs from field personnel, providing leadership with the timely data they need to make informed decisions.
SYNCHRO supports the entire heavy civil construction project lifecycle, empowering firms going digital with real-time insight into the performance, productivity, and financial health of their projects to make more-informed, data-driven decisions. Project teams stay connected and become collaborative with simple mobile and web interfaces for office-to-field workflows.
Image 1:
Caption: Virtual construction, planning, and model-based workflows from the field to office. Image courtesy of Bentley Systems.
Image 2:
Caption: Manage construction contracts, budgets, and change orders. Image courtesy of Bentley Systems.
Image 3:
Caption: Manage construction project performance, progress, and resources. Image courtesy of Bentley Systems.
Get to know SYNCHRO
Video:
https://players.brightcove.net/5209582030001/t50zJOlZh_default/index.html?videoId=6309547476112
Caption: Digital construction management for heavy civil infrastructure projects.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geoprofessional software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,500 colleagues and generates annual revenues of approximately $1 billion in 186 countries.
© 2022 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, Seequent, SYNCHRO, SYNCHRO 4D, SYNCHRO Control, SYNCHRO Cost, and SYNCHRO Perform are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110006078/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
